R. Pálmason

Genome-wide association study identifies a sequence variant within the DAB2IP gene conferring susceptibility to abdominal aortic aneurysm

Gerard Tromp, Helena Kuivaniemi, Kari Stefansson, 2010, Nature Genetics.

Recombinant factor VIIa as last‐resort treatment of desperate haemorrhage

P. T. Onundarson, G. Sigurdsson, R. Pálmason, 2012, Acta anaesthesiologica Scandinavica.

Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib

J. Richter, R. Pálmason, O. Lindén, 2015, BMC Hematology.

Development of acoustically isolated extracellular plasma vesicles for biomarker discovery in allogeneic hematopoietic stem cell transplantation

T. Laurell, S. Soneji, R. Pálmason, 2021, Biomarker research.

Screening for Monoclonal Gammopathy of Undetermined Significance: A Population-Based Randomized Clinical Trial. First Results from the Iceland Screens, Treats, or Prevents Multiple Myeloma (iStopMM) Study

I. Olafsson, P. T. Onundarson, B. Agnarsson, 2021, Blood.

Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE.

Fredrik Levander, Mats Ohlin, F. Levander, 2017, The Journal of allergy and clinical immunology.

Autoimmune Diseases Are Not Associated with Monoclonal Gammopathy of Undetermined Significance: Results of the Prospective Population-Based Istopmm Study

I. Olafsson, B. Agnarsson, T. Aspelund, 2022, Blood.

Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin

R. Pálmason, S. Lenhoff, S. Wichert, 2023, Scientific reports.

Association Between Autoimmune Diseases and Monoclonal Gammopathy of Undetermined Significance

P. T. Onundarson, B. Agnarsson, T. Aspelund, 2024, Annals of Internal Medicine.